KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Assets Average (2019 - 2025)

Historic Assets Average for BioNTech SE (BNTX) over the last 7 years, with Q3 2025 value amounting to $24.7 billion.

  • BioNTech SE's Assets Average rose 183.87% to $24.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $24.7 billion, marking a year-over-year increase of 183.87%. This contributed to the annual value of $24.4 billion for FY2024, which is 93.33% down from last year.
  • As of Q3 2025, BioNTech SE's Assets Average stood at $24.7 billion, which was up 183.87% from $23.4 billion recorded in Q2 2025.
  • BioNTech SE's 5-year Assets Average high stood at $24.7 billion for Q3 2025, and its period low was $3.9 billion during Q1 2021.
  • In the last 5 years, BioNTech SE's Assets Average had a median value of $23.4 billion in 2025 and averaged $20.9 billion.
  • As far as peak fluctuations go, BioNTech SE's Assets Average soared by 90547.73% in 2021, and later crashed by 526.39% in 2025.
  • BioNTech SE's Assets Average (Quarter) stood at $17.4 billion in 2021, then soared by 33.54% to $23.3 billion in 2022, then increased by 5.0% to $24.5 billion in 2023, then decreased by 0.51% to $24.3 billion in 2024, then grew by 1.57% to $24.7 billion in 2025.
  • Its Assets Average was $24.7 billion in Q3 2025, compared to $23.4 billion in Q2 2025 and $23.2 billion in Q1 2025.